Trailing-twelve-month (TTM) revenue is $146.62 Million with a year-over-year growth of +6.81%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $44,044,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q4 FY2025Period ended 2025-12-31 | $34,079,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q1 FY2026Period ended 2026-03-31 | $35,066,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $33,432,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $146,621,000 |
Current P/S: $15,304,285 market capitalization ÷ $146,621,000 TTM revenue = 0.10x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:20:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $33.43M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:22:29.038Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2020-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Health Care, Other | N/A | N/A | N/A | N/A | $3M | $572,000 |
| License | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD |
|---|---|
| CANADA | $5M |
$146.62M
$146.62 Million
+6.81%
vs. $137.27M a year ago (TTM)
+7.47%
5 Year compound annual growth rate
1 Year
+6.81%
3 Year
+0.14%
5 Year
+7.47%
10 Year
+97.93%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $146.07M | +$830,000 | +0.57% |
| 2024 | $145.24M | ($796,000) | (0.55%) |
| 2023 | $146.03M | ($11.04M) | (7.03%) |
| 2022 | $157.07M | ($52.74M) | (25.14%) |
| 2021 | $209.82M | +$101.73M | +94.12% |
| 2020 |
TTM Growth
+6.81%
3-Year CAGR
+0.14%
5-Year CAGR
+7.47%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 27 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:22:29.038Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $4M |
| N/A |
| N/A |
| License And Other | $32M | $111M | N/A | N/A | N/A | N/A |
|---|
| License and Service | N/A | N/A | $16M | $24M | $28M | $28M |
|---|
| Product | $76M | $98M | N/A | N/A | N/A | N/A |
|---|
| Royalty | N/A | N/A | $300,000 | $2M | N/A | N/A |
|---|
| $108.08M |
| +$67.19M |
| +164.31% |
| 2019 | $40.89M | +$10.56M | +34.80% |
| 2018 | $30.34M | +$28.73M | +1790.09% |
| 2017 | $1.60M | +$1.45M | +942.21% |
| 2016 | $154,000 | ($96,000) | (38.40%) |
